Bowhead Specialty (BOW)
Underwrites complex U.S. specialty casualty, professional, and healthcare liability risks.
$33.86
After hours−0.02 (−0.04%)
At close$33.88(+0.28%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 76 | 83 | 91 | 99 | 117 | 119 | 123 | 133 | 144 | 152 | 155 | 164 |
| Cost of revenue | 48 | 58 | 61 | 67 | 77 | 76 | 83 | 90 | 97 | 104 | 91 | 97 |
| Gross profit | 28 | 24 | 30 | 32 | 40 | 43 | 40 | 43 | 47 | 47 | 63 | 67 |
| 16 | 19 | 21 | 25 | 24 | 25 | 25 | 27 | 28 | 30 | 43 | 46 | |
| Other expenses | 16 | 19 | 21 | 25 | 24 | 25 | 25 | 27 | 28 | 30 | 43 | 46 |
| Operating income | 11 | 6 | 9 | 7 | 16 | 18 | 14 | 16 | 19 | 18 | 21 | 21 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 3 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −1 | −3 | −3 |
| Income before tax | 11 | 6 | 9 | 7 | 16 | 18 | 14 | 16 | 19 | 18 | 21 | 21 |
| Income tax expense | 3 | 1 | 2 | 2 | 4 | 5 | 3 | 4 | 4 | 3 | 5 | 5 |
| Net income from continuing operations | 9 | 5 | 7 | 6 | 12 | 14 | 11 | 12 | 15 | 15 | 16 | 16 |
| Net income | 9 | 5 | 7 | 6 | 12 | 14 | 11 | 12 | 15 | 15 | 16 | 16 |
| EPS, basic | $0.28 | $0.15 | $0.22 | $0.20 | $0.37 | $0.42 | $0.35 | $0.38 | $0.46 | $0.45 | $0.49 | $0.49 |
| EPS, diluted | $0.28 | $0.15 | $0.22 | $0.20 | $0.36 | $0.41 | $0.34 | $0.36 | $0.45 | $0.44 | $0.48 | $0.48 |
| Weighted average shares, basic | 32 | 32 | 32 | 28 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 |
| Weighted average shares, diluted | 32 | 32 | 32 | 28 | 33 | 34 | 34 | 34 | 34 | 34 | 33 | 34 |
| EBITDA | 12 | 7 | 10 | 9 | 17 | 20 | 15 | 17 | 20 | 20 | 24 | 26 |
| Depreciation & amortization | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 2 |
| EBIT | 11 | 6 | 9 | 8 | 16 | 18 | 15 | 16 | 19 | 19 | 24 | 24 |